Flow
cytometry is a laser- or impedance-based, biophysical technology
employed in cell counting, cell sorting, biomarker detection and
protein engineering. The process is conducted by suspending cells in
a stream of fluid and passing them through an electronic detection
apparatus. The simultaneous multiparametric analysis of the physical
and chemical characteristics of particles is facilitated by a flow
cytometer at a speed of up to thousands of particles per second. The
process is used in the diagnosis of health disorders such as blood
cancers along with several applications in basic research, clinical
practice, and clinical trials. Flow cytometry facilitates study of
the expression of cell surface and intracellular molecules along with
characterization of different cell types in a heterogeneous cell
population. Moreover, flow cytometry also allows simultaneous
multi-parameter analysis of single cells. The combination of
technological improvements, growing research activities in life
science and increasing clinical application of flow cytometry in
diagnosis of HIV and cancer are some of the major factors driving
growth of the flow cytometry market.
Free
Request Sample of Report:
https://www.coherentmarketinsights.com/insight/request-sample/1152
Flow
cytometry is recently undergone new developments with availability of
robust photodetectors and new laser emitters, use of LED lamps as
emitter, and changes in analytical capacity (multidimensional
analysis software). Furthermore, new approaches combining existing
technologies with routine laboratory procedures, such as imaging,
which makes the acquisition of images of cells possible in real time
as they pass by the interrogation point are some of the major
advancements in flow cytometry. The process also finds application in
cytology, hematology, immunology, and microbiology, among other
research fields.
The
global flow cytometry market was valued at US$ 3.2 Bn in 2016 and is
expected to witness a robust CAGR of 10.2 % over the forecast period
(2017-2025).
Increase
in clinical applications of flow cytometry is expected to favor the
flow cytometry market
The
use of flow cytometry in clinical laboratory has grown substantially
due to the development of smaller, user-friendly, less expensive
instruments and increasing number of research application such as,
immunophenotyping, cell sorting, cell cycle analysis, Apoptosis, cell
proliferation assays, and intracellular calcium flux is expected to
favor the growth of flow cytometry market. Besides, flow cytometry
has a unique ability to investigate large cell populations at the
single-cell level. This favors the adoption of flow cytometry for
clinical application.
Key
Players
Some
major players operating in the flow cytometry market are Becton
Dickinson and Company, General Electric Company, Luminex Corporation,
Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi
Biotec GmbH, Merck & Co Inc., Sysmex Corporation, Agilent
Technologies, Inc. and Danaher Corporation.
Detailed
Segmentation:
Global
Flow Cytometry Market, By Technology:
-
Cell Based
-
Bead Based
Global
Flow Cytometry Market, By Product:
-
Analyzer
-
Sorter
-
Reagents & Consumables
Find
the comprehensive research report here with a single click:
https://www.coherentmarketinsights.com/market-insight/flow-cytometry-market-1152
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment